Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression

NCT01977209 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Gossypol
DRUG: Placebo

Sponsor

Third Military Medical University